Back to Markets
ONOncolytics Biotech Inc

Oncolytics Biotech Inc

ONCYTORONTO STOCK EXCHANGE
Health CareBiotechnology

$1.04

+0.1000 (+11.23%)

As of 05/29/26 EDT · USD

Compare
Low: $0.3300Current: $1.04High: $1.51

Key Statistics

Open

$0.9500

Day High

$1.07

Day Low

$0.9100

Prev. Close

$0.9400

VolumeShares traded today.

2.83M

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$124.13M

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-3.47

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$1.51

52W LowLowest price over the past 52 weeks.

$0.3300

50D MAAverage closing price over the last 50 trading days.

$0.9347

200D MAAverage closing price over the last 200 trading days.

$1.04

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

+31.6%

1M

+19.4%

6M

+1.0%

YTD

+5.7%

1Y

+205.9%

About

Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses.

www.oncolyticsbiotech.com/

Company Facts

SectorHealth Care
IndustryBiotechnology
ExchangeTORONTO STOCK EXCHANGE
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade ONCY

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.